Advert - Astellas UK

Astellas UK voluntarily admitted that, over a long period of time, a large number of its promotional materials which referred to two medicines failed to include the prescribing information for both of those medicines. Prescribing information was omitted for Vesicare (solifenacin) and Prograf (tacrolimus). The company further admitted that it did not act immediately once the problem was discovered and it was ruled in breach of the following clauses of the Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry.
Clause 4.1 - Providing incomplete prescribing information.
Clause 9.1 - Failing to maintain high standards.

Advert - November 2017